Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.
P D Delmas, … , C Edouard, P J Meunier
P D Delmas, … , C Edouard, P J Meunier
Published March 1, 1986
Citation Information: J Clin Invest. 1986;77(3):985-991. https://doi.org/10.1172/JCI112400.
View: Text | PDF
Research Article

Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.

  • Text
  • PDF
Abstract

Serum bone gamma-carboxyglutamic acid-containing (Gla) protein (sBGP), a sensitive and specific marker of bone turnover, was measured in 25 patients with primary hyperparathyroidism and in 24 patients with bone metastases with or without hypercalcemia. Despite similar levels of hypercalcemia, sBGP was increased in primary hyperparathyroidism (14.2 +/- 9.6 ng/ml, P less than 0.001), was decreased in malignant hypercalcemia (3.1 +/- 2.8 ng/ml, P less than 0.001), and was normal in patients with bone metastases without hypercalcemia (6.6 +/- 2.7 ng/ml). In primary hyperparathyroidism, sBGP was correlated with serum immuno-reactive parathyroid hormone (r = 0.90), calcium (r = 0.73), and with the adenoma weight (r = 0.79). After parathyroidectomy, sBGP slowly returned to normal values within 2-6 mo, suggesting that sBGP reflects increased bone turnover rather than a direct effect of parathyroid hormone on BGP synthesis at the cell level. An iliac crest biopsy was performed in 11 patients with primary hyperparathyroidism and in 9 cancer patients in a noninvaded area. sBGP was significantly correlated with all parameters reflecting bone formation but not with bone resorption. Patients with bone metastases were analyzed according to the presence or the absence of hypercalcemia. In contrast to normocalcemic patients who had normal sBGP, hypercalcemic patients had decreased sBGP (P less than 0.001) and a lower bone formation at the cellular level (P less than 0.05). Thus, biochemical and histological data suggest that an unknown humoral factor might be responsible for this uncoupling between increased resorption and decreased formation. This uncoupling, rather than local release of calcium by the metastatic process, might be responsible for hypercalcemia in patients with bone metastases.

Authors

P D Delmas, B Demiaux, L Malaval, M C Chapuy, C Edouard, P J Meunier

×

Total citations by year

Year: 2024 2022 2021 2020 2018 2017 2016 2015 2014 2012 2011 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1955 Total
Citations: 1 2 2 2 2 1 1 1 1 2 1 4 2 2 2 1 2 2 2 1 2 2 3 4 4 5 3 6 5 5 13 6 11 3 1 1 108
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (108)

Title and authors Publication Year
Influence of N- and/or P-restriction on bone metabolism in young goats
Zillinger LS, Liesegang A, Hustedt K, Schnepel N, Sauerwein H, Schmicke M, Schwennen C, Muscher-Banse AS
The British Journal of Nutrition 2024
Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.
Ladang A, Rauch F, Delvin E, Cavalier E
Calcified Tissue International 2022
12 Weeks of Physical Exercise Attenuates Oxidative Stress, Improves Functional Tests Performance, and Reduces Fall Risk in Elderly Women Independently on Serum 25(OH)D Concentration.
Rodziewicz-Flis EA, Kawa M, Flis DJ, Szaro-Truchan M, Skrobot WR, Kaczor JJ
Frontiers in physiology 2022
Bone Phenotyping Approaches in Human, Mice and Zebrafish – Expert Overview of the EU Cost Action GEMSTONE (“GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork”)
I Foessl, JH Bassett, Å Bjørnerem, B Busse, Â Calado, P Chavassieux, M Christou, E Douni, IA Fiedler, JE Fonseca, E Hassler, W Högler, E Kague, D Karasik, P Khashayar, BL Langdahl, VD Leitch, P Lopes, G Markozannes, FE McGuigan, C Medina-Gomez, E Ntzani, L Oei, C Ohlsson, P Szulc, JH Tobias, K Trajanoska, Ş Tuzun, A Valjevac, B van Rietbergen, GR Williams, T Zekic, F Rivadeneira, B Obermayer-Pietsch
Frontiers in Endocrinology 2021
Peptidomimetic inhibitor of L-plastin reduces osteoclastic bone resorption in aging female mice
H Aljohani, JP Stains, S Majumdar, D Srinivasan, L Senbanjo, MA Chellaiah
Bone Research 2021
Functionalization of a clustered TiO2 nanotubular surface with platelet derived growth factor-BB covalent modification enhances osteogenic differentiation of bone marrow mesenchymal stem cells
Q Ma, N Jiang, S Liang, F Chen, L Fang, X Wang, J Wang, L Chen
Biomaterials 2020
Biochemical bone turnover markers in hormonal disorders in adults: a narrative review
P Szulc
Journal of Endocrinological Investigation 2020
Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts
AB Shupp, AD Kolb, D Mukhopadhyay, KM Bussard
Cancers 2018
Laboratory aspects and clinical utility of bone turnover markers
Harjit Pal Bhattoa
EJIFCC 2018
Changes of Bone Turnover Markers in Long Bone Nonunions Treated with a Regenerative Approach
D Granchi, E Gómez-Barrena, M Rojewski, P Rosset, P Layrolle, B Spazzoli, DM Donati, G Ciapetti
Stem Cells International 2017
Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease
MB Greenblatt, JN Tsai, MN Wein
Clinical chemistry 2016
Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
P Chavassieux, N Portero-Muzy, JP Roux, P Garnero, R Chapurlat
The Journal of clinical endocrinology and metabolism 2015
Evaluation of in vitro Efficacy of Vitamin D3 on the Osteogenic Differentiation and Mineralization Capabilities of Fetal and Adult Osteoblasts of Rabbit Reflects Therapeutic Potential
R Pathak, A ., P Tamilmahan, K Dhama, N Sharma
International Journal of Pharmacology 2014
Human adipose tissue-derived stromal cell therapy prevents bone loss in ovariectomized nude mouse
SW Cho, HJ Sun, JY Yang, JY Jung, HJ Choi, JH An, SW Kim, SY Kim, KJ Park, CS Shin
Tissue Engineering Part A 2012
The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
P Szulc
Clinical Biochemistry 2012
The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy
S Alonso, E Ferrero, M Donat, G Martínez, C Vargas, M Hidalgo, E Moreno
Journal of Endocrinological Investigation 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy
P Boudou, F Ibrahim, C Cormier, E Sarfati, JC Souberbielle
Journal of Bone and Mineral Metabolism 2009
Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer
YC Chen, DM Sosnoski, UH Gandhi, LJ Novinger, KS Prabhu, AM Mastro
Carcinogenesis 2009
Osteocalcin Attenuates T3- and Increases Vitamin D3-Induced Expression of MMP-13 in Mouse Osteoblasts
F VARGA, M RUMPLER, S SPITZER, H KARLIC, K KLAUSHOFER
Endocrine Journal 2009
Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis
P Szulc, PD Delmas
Osteoporosis International 2008
Bone turnover markers: An appreciation of the contribution of Dr. P.D. Delmas
R Eastell
Bone 2008
The bone microenvironment in metastasis; what is special about bone?
KM Bussard, CV Gay, AM Mastro
Cancer and Metastasis Reviews 2007
Posttransplant bone disease
N Agrawal, MA Josephson
Transplantation Reviews 2007
The testosterone mimetic properties of icariin
ZB Zhang, QT Yang
Asian Journal of Andrology 2006
Dynamics of Bone and Cartilage Metabolism
JE Mulder, CA Kulak, E Shane
Dynamics of Bone and Cartilage Metabolism 2006
Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K
RR Mercer, AM Mastro
Experimental Cell Research 2005
Bone mineral density and bone turnover markers in children with chronic renal failure
AM Bakr
Pediatric Nephrology 2004
Metastatic breast cancer cells suppress osteoblast adhesion and differentiation
RR Mercer, C Miyasaka, AM Mastro
Clinical & Experimental Metastasis 2004
Matrix molecules and growth factors as indicators of periodontal disease activity
WV Giannobile, KF Al-Shammari, DP Sarment
Periodontology 2000 2003
Markers of Bone Remodeling in Metastatic Bone Disease
B Fohr, CR Dunstan, MJ Seibel
The Journal of clinical endocrinology and metabolism 2003
Pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen in uremic hyperparathyroidism
T Hatada, H Ikeda, Y Fujiwara, K Yoh, T Yamamura
Nephrology 2002
Acoustical Imaging
H Lee
2002
The Parathyroids
SJ Marx
The Parathyroids 2001
Vitamin K supplementation reduces serum concentrations of under-γ-carboxylated osteocalcin in healthy young and elderly adults
NC Binkley, DC Krueger, JA Engelke, AL Foley, JW Suttie
The American journal of clinical nutrition 2000
Measurement of Osteocalcin
AJ Lee, S Hodges, R Eastell
Annals of Clinical Biochemistry 2000
Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study
H Engler, RE Oettli, WF Riesen
Clinica Chimica Acta 1999
Bone Turnover in Preterm Infants
KE Naylor, R Eastell, KE Shattuck, AC Alfrey, GL Klein
Pediatric Research 1999
Calciotropic Hormones and Bone Markers in the Elderly
JC Gallagher, HK Kinyamu, SE Fowler, B Dawson-Hughes, GP Dalsky, SS Sherman
Journal of Bone and Mineral Research 1998
BIOCHEMICAL MARKERS OF BONE TURNOVER
P Garnero, PD Delmas
Endocrinology and metabolism clinics of North America 1998
Cancer and Bone*
TA Guise, GR Mundy
Endocrine reviews 1998
Osteoporosis
DL Glaser, FS Kaplan
Spine 1997
Osteocalcin (BGP), Gene Expression, and Protein Production by Marrow Stromal Adipocytes
D Benayahu, A Shamay, S Wientroub
Biochemical and Biophysical Research Communications 1997
4 Bone markers
P Garnero, PD Delmas
Baillière's Clinical Rheumatology 1997
Hypercalcemia of Malignancy
GR MD, TA MD
The American Journal of Medicine 1997
New developments in biochemical markers for osteoporosis
P Garnero, PD Delmas
Calcified Tissue International 1996
Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma
M Laroche, M Attal, C Dromer
Clinical Rheumatology 1996
Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment
J Vinholes, R Coleman, R Eastell
Cancer Treatment Reviews 1996
Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole
G Lupoli, V Nuzzo, CD Carlo, P Affmito, M Vollery, G Vitale, E Cascone, F Arlotta, C Nappi
Gynecological Endocrinology 1996
A comparison of the effects of parathyroid hormone and parathyroid hormone-related protein on osteocalcin in the rat
CM Gundberg, MI Fawzi, ME Clough, MS Calvo
Journal of Bone and Mineral Research 1995
Osteocalcin in congenital adrenal hyperplasia
L Lisá, M Neradilová, N Tomášová, M Soutorová, J Zimák
Bone 1995
Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study
SJ Wimalawansa
The American Journal of Medicine 1995
Evaluation of bone loss and the serum markers of bone metabolism in patients with hyperparathyroidism
M Katagiri, T Ohtawa, M Fukunaga, T Harada
Surgery Today 1995
Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des Recherches Pharmaceutiques
VK Singh, ME Gnegy, SP Gupta, R Leurs, RC Vollinga, H Timmerman, RW Fuller, NC Cohen, V Tschinke, EJ Benaksas, ED Murray, WJ Wechter, I Dwivedy, S Ray, E Jucker
1995
Systemic bone growth factors in light breed mares and their foals
MJ Davicco, Y Faulconnier, V Coxam, H Dubroeucq, W Martin-Rosset, JP Barlet
Archives Of Physiology And Biochemistry 1994
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer
T Taube, I Elomaa, C Blomqvist, MN Beneton, JA Kanis
Bone 1994
Metastatic Bone Disease
IJ Diel, M Kaufmann, G Bastert
1994
Biochemical markers of bone turnover
PD Delmas
Journal of Bone and Mineral Research 1993
Biochemical markers of bone turnover in women with surgically treated carcinoma of the breast
F Li, PI Pitt, R Sherwood, J Barrettt, J Houghton, V Parsons, C Moniz
European Journal of Clinical Investigation 1993
Serum bone Gla protein as a marker of bone turnover in acromegaly
M Marazuela, B Astigarraga, MJ Tabuenca, J Estrada, F Marn, T Lucas
Calcified Tissue International 1993
Physiology and Pharmacology of Bone
GR Mundy, TJ Martin
1993
Biochemical markers of bone turnover for the clinical investigation of osteoporosis
PD Delmas
Osteoporosis International 1993
Osteologie aktuell VII
HJ Pesch, H Stöß, B Kummer
1993
Effect of a single infusion of alendronate in malignant hypercalcaemia: Dose dependency and comparison with clodronate
R Rizzoli, B Buchs, JP Bonjour
International Journal of Cancer 1992
Serum intact molecule of bone Gla-protein in patients with abnormal bone and calcium metabolism
K Nakatsuka, T Miki, S Shoji, Y Nishizawa, H Morii
Journal of Bone and Mineral Metabolism 1992
Effect of fluoride on bone and bone cells in ovariectomized rats
D Modrowski, L Miravet, M Feuga, F Bannié, PJ Marie
Journal of Bone and Mineral Research 1992
Insulin-like growth factor-II increases plasma osteocalcin concentration in newborn lambs
V Coxam, MJ Davicco, P Pastoureau, PD Delmas, JP Barlet
Bone and Mineral 1992
Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis
N Kojima, S Sakata, S Nakamura, K Nagai, H Takuno, T Ogawa, I Matsui, H Sarui, K Miura
Journal of Endocrinological Investigation 1992
Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment
L Mosekilde, EF Eriksen, P Charles
Critical Reviews in Oncology/Hematology 1991
Serum osteocalcin levels in primary hyperparathyroidism
P Pietschmann, B Niederle, A Anvari, W Woloszczuk
Klinische Wochenschrift 1991
Serum markers of bone formation in parenteral nutrition patients
AM Parfitt
Calcified Tissue International 1991
Serum osteocalcin (Bone Gla-Protein), an index of bone growth in lambs. Comparison with age-related histomorphometric changes
P Pastoureau, PJ Meunier, PD Delmas
Bone 1991
3 What do we know about biochemical bone markers?
PD Delmas
Baillière's Clinical Obstetrics and Gynaecology 1991
Abnormal serum bone gla protein levels in multiple myeloma: Crucial role of bone formation and prognostic implications
R Bataille, PD Delmas, D Chappard, J Sany
Cancer 1990
Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women
ME Arlot, PD Delmas, D Chappard, PJ Meunier
Osteoporosis International 1990
Serum markers of bone formation in parenteral nutrition patients
EW Lipkin, SM Ott, GL Klein, LJ Deftos
Calcified Tissue International 1990
Bone gla protein (osteocalcin) assay standardization report
PD Delmas, C Christiansen, KG Mann, PA Price
Journal of Bone and Mineral Research 1990
Parathyroid hormone-related protein and hypercalcemia in pancreatic neuro-endocrine tumors
R Rizzoli, AP Sappino, JP Bonjour
International Journal of Cancer 1990
Clinical Utility of Serum Osteocalcin
HA Fritsche
Cancer Investigation 1990
Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase
C Vermeer
Biochemical Journal 1990
Hypercalcemia in malignancy
GJ Strewler, RA Nissenson
The Western journal of medicine 1990
Normal car☐ylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone
B Merle, PD Delmas
Bone and Mineral 1990
The response of circulating parameters of bone mineral metabolism to ethanol- and EDTA-induced hypocalcemia in the rat
S Thomas, C Movsowitz, S Epstein, P Jowell, F Ismail
Bone and Mineral 1990
New Techniques in Metabolic Bone Disease
R Lindsay
New Techniques in Metabolic Bone Disease 1990
Biochemical Markers of Bone Turnover for the Clinical Assessment of Metabolic Bone Disease
PD Delmas
Endocrinology and metabolism clinics of North America 1990
Serum Bone Gla-Protein in Hypercalcemia of Primary Hyperparathyroidism and Malignancy
RD Virgilio, MD Lazzari, GD Rin, P Legovini, G Foscolo, I Roiter, N Conte
TUMORI 1990
Bone gla: Protein in blood derived directly from human bone tissue
KJ Obrant, U Bengnér, PD Delmas
Calcified Tissue International 1989
Bone-derived proteins
S Epstein
Trends in Endocrinology & Metabolism 1989
Clinical Impact of Bone and Connective Tissue Markers
PD Delmas
Clinical Impact of Bone and Connective Tissue Markers 1989
Histomorphometric Analysis of Bone in Metabolic Bone Disease
EF Eriksen, T Steiniche, L Mosekilde, F Meisen
Endocrinology and metabolism clinics of North America 1989
Etiologies and Therapy of Hypercalcemia
JP Bilezikian
Endocrinology and metabolism clinics of North America 1989
Serum osteocalcin levels in breast cancer patients
P Pietschmann, C Zielinski, W Woloszczuk
Journal of Cancer Research and Clinical Oncology 1989
Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism
K Mizunashi, Y Furukawa, R Miura, S Yumita, HE Sohn, K Yoshinaga
Journal of Clinical Investigation 1988
Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy
PS Jowell, S Epstein, F Ismail, B Hollis, IR Schwartz
Calcified Tissue International 1988
Osteocalcin and bone morphometric parameters in adults without bone disease
M Garcia-Carrasco, M Gruson, MC Vernejoul, M Denne, L Miravet
Calcified Tissue International 1988
PTH mRNA transcription analysis in infantile tumors associated with hypercalcemia
MF Rousseau-Merck, C Nezelof, YD Keyzer, A Bourdeau, G Cournot, F Mercier
Cancer 1988
Can serum osteocalcin levels predict bone turnover in patients with osteoporosis?
T Tsunenari, M Takenaka, M Fukase, T Fujita
Journal of Bone and Mineral Metabolism 1988
Effects of moderate physical training on prednisone-induced protein wasting: A study of whole-body and bone protein metabolism
DR Garrel, PD Delmas, C Welsh, MJ Arnaud, SE Hamilton, MM Pugeat
Metabolism 1988
Hypercalcemia
JP Bilezikian
Disease-a-Month 1988
Osteocalcin: a potential marker of metastatic bone disease and response to treatment
RE Coleman, G Mashiter, I Fogelman, KD Whitaker, M Caleffi, DW Moss, RD Rubens
European Journal of Cancer and Clinical Oncology 1988
Cyclic AMP-mediated stabilization of osteocalcin mRNA in rat osteoblast-like cells treated with parathyroid hormone
M Noda, K Yoon, GA Rodan
The Journal of biological chemistry 1988
Osteocalcin and bone morphometric parameters in adults without bone disease
M Garcia-Carrasco, M Gruson, MC de Vernejoul, M annick Denne, L Miravet
Calcified Tissue International 1988
Correlation among plasma osteocalcin, growth hormone, and somatomedin C in acromegaly
C de la Piedra, E Carbó, J Larrañaga, N Castro, C Horcajada, A Rapado, JL Pombo
Calcified Tissue International 1988
Serum bone gla-protein in multiple myeloma
R Bataille, P Delmas, J Sany
Cancer 1987
Evaluation of mineral metabolism and bone turnover in osteoporotic females treated with phosphorus and salmon calcitonin
FP Cantatore, M Carrozzo, DM Magli, M D'Amore, V Pipitone
Clinical Rheumatology 1987
Radioimmunoassay for osteonectin. Concentrations in bone, nonmineralized tissues, and blood
L Malaval, B Fournier, PD Delmas
Journal of Bone and Mineral Research 1987
Serum osteocalcin (BGP) in tumor-associated hypercalcemia
JJ Body, A Cleeren, M Pot, A Borkowski
Journal of Bone and Mineral Research 1986
OSTEOPOROSIS
AM Cooks
The Lancet 1955

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts